Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,122.17
(
0.82%
)
US TECH 100
26,086.80
(
1.22%
)
Dow Jones
49,525.11
(
0.16%
)
Brent Oil
96.84
(
1.92%
)
Bitcoin
78,995.09
(
3.49%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jakedogman1

Send PM Follow Ignore
Followers 31
Posts 5818
Boards Moderated 0
Alias Born 05/23/2006

jakedogman1

Re: cjgaddy post# 329081

Thursday, 10/18/2018 3:03:29 PM

Thursday, October 18, 2018 3:03:29 PM

Post# of 347009
thx... looks like Sorafenib and Bavituximab trial canned due to lack of interest and Bavituximab With Radiation and Temozolomide has fully enrolled ahead of schedule per clinicaltrials.gov. The keytruda trial has not been updated recently.

https://www.oncologie.international/ongoing-trials/
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote